Journal
CONTACT DERMATITIS
Volume 89, Issue 3, Pages 190-197Publisher
WILEY
DOI: 10.1111/cod.14377
Keywords
68647-73-4; 92201-50-8; allergic contact dermatitis; essential oil; fragrance; lavender oil or Lavandula augustifolia; patch tests; Ravintsara oil or Cinnamomum camphora oil; tea tree oil or Melaleuca alternifolia leaf oil
Categories
Ask authors/readers for more resources
The aim of this study was to analyze the clinical characteristics and sensitivity of an essential oil patch test series in patients sensitized to their own essential oils. The study included 42 patients with allergic contact dermatitis, who were found to be sensitized to the essential oils they used. The study concluded that patch tests with the European baseline series, limonene and linalool HP, and oxidized tea tree oil can effectively detect most essential oil-sensitized patients.
ObjectiveTo analyse the clinical characteristics and sensitivity of an essential oil patch test series (EOS) in patients sensitized to their own essential oils (EOs). MethodWe analysed the clinical data and patch test results obtained with the European baseline series (BSE) and an EOS, as well as the mode of use of EOs, through a questionnaire included in the patient file. ResultsThe study included 42 patients (79% women, average age 50years) with allergic contact dermatitis (ACD), 8 patients required hospitalization. All patients were sensitized to the EO they used, primarily lavender (Lavandula augustifolia, 8000-28-0), tea tree (Melaleuca alternifolia leaf oil, 68647-73-4), ravintsara (Cinnamomum camphora oil, 92201-50-8), and 2 cases were attributed to helichrysum (helichrysum italicum flower absolute, 90045-56-0). 71% had positive patch tests to fragrance mix I or II, 9 only to the EOS and 4 only with their personal EO. Interestingly, 40% of patients did not spontaneously mention the use of EOs, and only 33% received advice on their use at the time of purchase. ConclusionPatch tests with the BSE, limonene and linalool HP, and oxidized tea tree oil is sufficient to detect most EO-sensitized patients. The most important is to test the patient's own used EOs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available